Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bed Bath & Beyond Inc. (BBBY): Insiders Aren’t Crazy About It

Page 1 of 2

Bed Bath & Beyond Inc. (NASDAQ:BBBY) investors should pay attention to a decrease in enthusiasm from smart money in recent months.

At the moment, there are dozens of metrics shareholders can use to track stocks. Some of the best are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the elite money managers can beat their index-focused peers by a healthy margin (see just how much).

Bed Bath & Beyond Inc. (NASDAQ:BBBY)Equally as important, bullish insider trading activity is a second way to parse down the marketplace. Just as you’d expect, there are a variety of stimuli for an upper level exec to get rid of shares of his or her company, but only one, very simple reason why they would buy. Various empirical studies have demonstrated the impressive potential of this strategy if piggybackers understand where to look (learn more here).

Keeping this in mind, we’re going to take a peek at the key action regarding Bed Bath & Beyond Inc. (NASDAQ:BBBY).

How have hedgies been trading Bed Bath & Beyond Inc. (NASDAQ:BBBY)?

At Q1’s end, a total of 28 of the hedge funds we track were long in this stock, a change of -10% from the previous quarter. With hedge funds’ capital changing hands, there exists an “upper tier” of notable hedge fund managers who were boosting their holdings substantially.

According to our comprehensive database, Royce & Associates, managed by Chuck Royce, holds the largest position in Bed Bath & Beyond Inc. (NASDAQ:BBBY). Royce & Associates has a $150.1 million position in the stock, comprising 0.5% of its 13F portfolio. Coming in second is Jeffrey Gates of Gates Capital Management, with a $90.3 million position; the fund has 4.7% of its 13F portfolio invested in the stock. Remaining peers that hold long positions include David Costen Haley’s HBK Investments, John Osterweis’s Osterweis Capital Management and Jim Simons’s Renaissance Technologies.

Due to the fact that Bed Bath & Beyond Inc. (NASDAQ:BBBY) has faced a declination in interest from hedge fund managers, we can see that there were a few hedgies that slashed their positions entirely heading into Q2. Interestingly, Bruce Kovner’s Caxton Associates LP dumped the biggest position of the “upper crust” of funds we monitor, worth an estimated $28 million in call options, and Phill Gross and Robert Atchinson of Adage Capital Management was right behind this move, as the fund dumped about $27.3 million worth. These moves are intriguing to say the least, as total hedge fund interest was cut by 3 funds heading into Q2.

How are insiders trading Bed Bath & Beyond Inc. (NASDAQ:BBBY)?

Bullish insider trading is particularly usable when the company in focus has seen transactions within the past six months. Over the last 180-day time frame, Bed Bath & Beyond Inc. (NASDAQ:BBBY) has seen zero unique insiders purchasing, and 6 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Bed Bath & Beyond Inc. (NASDAQ:BBBY). These stocks are Gordmans Stores, Inc. (NASDAQ:GMAN), Haverty Furniture Companies, Inc. (NYSE:HVT), Restoration Hardware Holdings Inc (NYSE:RH), Pier 1 Imports, Inc. (NYSE:PIR), and Williams-Sonoma, Inc. (NYSE:WSM). All of these stocks are in the home furnishing stores industry and their market caps match BBBY’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!